Answers are grounded in this paper and cite their sources.
The incidence of major gastrointestinal bleeding (GIB) in patients on low-dose direct-acting oral anticoagulants (DOACs) is relatively unknown. Estimates from randomised controlled trials (RCTs) are lacking.
No takes yet. Share an insight, caveat, or question.
Forbes et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: